MedPath

MISSION! REMOTE Telemonitoring of Implantable Cardioverter Defibrillators: A randomized controlled trial

Conditions
Cardiac Arrhythmia
10007521
Registration Number
NL-OMON32998
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

Indication for ICD or CRT-D
18 years of older
Capability to use either telemonitoring system throughout 12 months (Biotronik's Home Monitoring or Medtronic's CareLink)

Exclusion Criteria

Congenital heart disease
Instable Medical condition

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary purpose of this study is to evaluate whether telemonitoring can<br /><br>decrease the follow-up burden for ICD/CRT-D patients and clinic. Therefore, the<br /><br>number of interrogations will be assessed. Secondly the feasibility of<br /><br>telemonitoring will be tested by assessing the number of data-transmissions,<br /><br>patient compliance, ease of use and satisfaction. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The first secondary objective will be to assess the value of asymptomatic<br /><br>events and alerts, as detected by telemonitoring. Early detection and<br /><br>resolution of silent events hold obvious promise in the advancement of patient<br /><br>care.<br /><br>In the second secondary objective, the potential cost benefit of telemonitoring<br /><br>will be assessed.<br /><br>Thirdly, the additional information acquired by telemonitoring will be<br /><br>assessed. The ICDs/CRT-Ds used in this study are equipped with several<br /><br>monitoring features, which are innovative but not (yet) implemented in current<br /><br>guidelines </p><br>
© Copyright 2025. All Rights Reserved by MedPath